Influenza

New insights on influenza genome packaging could guide strategies for interfering with the virus's life cycle and ability to cause infection. Read More

An influenza diagnosis for people 65 and older is serious. Up to 85 percent of influenza-related deaths occur in older adults, the Centers for Disease Control (CDC) and Prevention reports. Read More

From Vanderbilt Magazine: James Crowe, director of the Vanderbilt Vaccine Center, hopes to create a universal flu vaccine--permanently eliminating the problem of ineffective or under-effective annual flu shots. Read More

Neighborhood determinants – represented by census tract data – contribute to the risk of influenza hospitalization and could be used to guide interventions such as vaccinations to high-risk areas. Read More

Researchers at Vanderbilt University Medical Center are leading an international effort to develop a universal influenza vaccine that would protect everyone against all strains of the flu anywhere in the world. Read More

More than half of hospitalizations due to influenza pneumonia could be prevented by influenza vaccination, according to a study led by investigators at Vanderbilt University Medical Center, published this week in the Journal of the American Medical Association. Read More

Vanderbilt investigators have discovered how human antibodies induced during testing of an experimental “bird flu” vaccine kill the virus. Read More

A study appearing in the January edition of Pediatrics, led by researchers at Vanderbilt University Medical Center, looks at how Nashville children ages 6 months through 5 years fared over 11 consecutive flu seasons concluding in 2010-11. Read More

Compounds developed at Vanderbilt University may offer a new way to block influenza infection. Read More

High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications. Read More